Amantadine is one of the odder drugs in veterinary pain management. It was originally developed as a human antiviral for influenza A, it is also used in human neurology (Parkinson's disease), and in veterinary medicine it has found a third life as an adjunct for chronic and neuropathic pain. It is not an NSAID, it is not an opioid, and — this is the part owners most often misunderstand — it is not meant to be used alone. Amantadine's job is to quiet the "volume knob" the nervous system turns up when pain becomes chronic, so that the drugs doing the real work (an NSAID, gabapentin, an opioid) can be heard again.

This article covers how amantadine works, which dogs benefit, the dose ranges and timing veterinarians consider, the side effects, and where it fits in a multimodal pain plan.

One label point up front: amantadine is not FDA-approved for use in dogs or cats. Every prescription is extra-label (off-label), based on the veterinarian applying human pharmacology and the published veterinary pain literature to the individual patient. That is legal and routine in veterinary medicine, but it is also why the dose, the combination, and the trial length come from clinical judgment and studies rather than an animal-specific label.

The problem amantadine solves: central sensitization

When pain signals keep firing for weeks or months — advanced osteoarthritis, a herniated disc, a slow-growing bone tumor — the spinal cord and brain stop transmitting them faithfully and start amplifying them. The nervous system becomes hyper-excitable: things that should hurt a little hurt a lot (hyperalgesia), and things that should not hurt at all — a light touch, cold weather, simply being touched near a sore joint — start to hurt (allodynia). This is called central sensitization, or colloquially "wind-up," and it is why a dog with long-standing arthritis can look more painful than the X-rays alone would predict.

Central sensitization is driven partly by N-methyl-D-aspartate (NMDA) receptors in the spinal cord. Amantadine is a non-competitive NMDA receptor antagonist — it blocks (more precisely, accelerates the closure of) those channels and dampens the amplification. It is technically an antihyperalgesic rather than a classic analgesic: it lowers exaggerated pain rather than blocking normal pain on its own. That single fact explains almost everything about how it is prescribed.

What amantadine is used for in dogs

Because it targets sensitized pain pathways, amantadine is reserved for chronic or neuropathic pain, not acute, short-term pain. Typical uses include:

• Osteoarthritis that is no longer controlled by an NSAID alone. This is the best-studied veterinary use. In a randomized, placebo-controlled trial (Lascelles and colleagues, Journal of Veterinary Internal Medicine, 2008), dogs with OA pain that had become refractory to an NSAID (meloxicam) were more active and scored lower on lameness when amantadine (3–5 mg/kg once daily for 21 days) was added, compared with NSAID alone.
• Neuropathic pain — for example, degenerative lumbosacral stenosis, intervertebral disc disease, or nerve injury. A more recent canine study of degenerative lumbosacral stenosis supported amantadine as a helpful part of conservative management.
• Cancer pain, including osteosarcoma and other tumors where pain escalates — frequently used in palliative and hospice care alongside an NSAID and gabapentin.
• Breakthrough worsening of chronic pain — a dog who was stable and suddenly hurts more than the disease progression would explain.

For early or mild osteoarthritis, amantadine is generally not the first choice; an NSAID (or an anti-NGF monoclonal antibody such as Librela) comes first, with gabapentin and then amantadine layered in as pain becomes harder to control.

Dose ranges, onset, and why patience matters

The commonly cited dose for dogs (and cats) is 3–5 mg/kg by mouth, once to twice daily, with twice-daily dosing preferred based on more recent pharmacokinetic data showing a short half-life (about 5–6 hours). A typical starting approach is once-daily dosing in the morning, moving to twice daily after several days if needed, with every-8-hour dosing reserved for severe pain. The exact dose and schedule are set by the veterinarian based on the individual dog, the other drugs in the plan, and kidney function; the ranges here are context, not a prescription.

Two timing realities are essential:

1. It takes time. Reversing central sensitization is a slow process. The minimum recommended trial is about 21 days before judging whether amantadine is helping, and many dogs need it for months or for life. Some owners see improvement within a few days, but giving up after a week is the most common reason the drug is wrongly called ineffective.
2. It is not a rescue drug. Because the effect builds over weeks, amantadine does not replace a fast-acting pain reliever for an acute flare. It is the long-term layer, not the short-term one.

Amantadine may be given with food to reduce mild stomach upset. It is available as 15, 50, and 100 mg capsules and as a 50 mg/mL oral suspension; it is a human generic and is often less expensive filled at a retail pharmacy than through a veterinary wholesaler.

Side effects

Amantadine is generally well tolerated. Reported adverse effects are uncommon and usually mild:

• Gastrointestinal: diarrhea, flatulence, mild upset — often most noticeable in the first days of therapy.
• Behavioral: restlessness, mild agitation, or excitability — again, usually early and often transient.

Serious adverse effects are uncommon at therapeutic doses. Because the drug is cleared by the kidneys, dogs with kidney disease may need dose adjustment and longer intervals, and senior dogs with reduced renal function should start at the lower end of the range.

Interactions and cautions

Because amantadine also has dopaminergic and mild serotonergic activity, it warrants caution in a few situations:

• Serotonergic drugs — combining amantadine with SSRIs (such as fluoxetine/Reconcile), tricyclics (clomipramine), trazodone, or tramadol can, in principle, raise serotonin-syndrome risk. This does not forbid combination, but the veterinarian should be aware of all behavior and pain medications the dog is taking.
• Seizure disorders — at high doses, amantadine can lower the seizure threshold, so it is used cautiously in epileptic dogs.
• Kidney disease — dose reduction/extension of dosing intervals (renal clearance).
• Cardiac disease, congestive heart failure, or a history of hallucinations/psychosis (in human labeling) — use with caution.
• Pregnancy/lactation — safety not established.

A historical footnote worth knowing: amantadine and related adamantanes were banned by the FDA for use in poultry in 2006 over avian-influenza resistance concerns. That ban has no bearing on its use in dogs and cats, but it is why the drug's "antiviral" origin still appears on its labeling.

How amantadine fits a multimodal plan

Modern chronic-pain management in dogs is explicitly multimodal — combining drugs that work through different mechanisms so that lower doses of each can be used with better effect. Amantadine is one layer:

• NSAID or anti-NGF monoclonal antibody (carprofen, meloxicam, grapiprant, or Librela/bedinvetmab) — the anti-inflammatory foundation.
• Gabapentin (or pregabalin) — the first-line drug for known nerve damage or neuropathic components; pairs with the NSAID.
• Amantadine — added when central sensitization is suspected, especially when pain is suddenly worse than the disease explains, or when the NSAID-plus-gabapentin combination has stalled.
• Non-drug layers — weight management, physical rehabilitation, joint supplements, therapeutic laser, acupuncture, assistive devices — which are not optional extras for chronic OA but part of evidence-based chronic-pain management.

A practical rule of thumb used by pain clinicians: for known nerve injury, reach first for a gabapentinoid; for pain that is suddenly worse than expected with no clear worsening of the disease, reach first for amantadine. In severe chronic pain, both may be used together alongside an NSAID.

What to ask your veterinarian

• What role is amantadine playing in my dog's plan? It should be an adjunct to a primary analgesic (NSAID or anti-NGF), not a standalone drug.
• How long a trial before we decide it's working? Plan for roughly three weeks; ask what "success" looks like (activity level, willingness to rise, stairs, specific mobility goals).
• Is my dog's kidney function normal? Renal bloodwork guides the dose, especially in seniors.
• What other pain or behavior medications is my dog on? All serotonergic drugs (fluoxetine, clomipramine, trazodone, tramadol) and seizure medications need to be on the list.
• What is the full multimodal plan — including weight, rehab, and the primary analgesic — so amantadine is not expected to carry the load alone?

Amantadine will not make a dog with advanced arthritis feel better in an hour, and it will not work as a solo act. What it does, given a few weeks and a real multimodal plan, is turn down the volume on pain that an NSAID alone can no longer reach — which is often exactly the kind of pain that has stopped responding to anything else.

Sources

• Lascelles BDX, Gaynor JS, Smith ES, et al. Amantadine in a Multimodal Analgesic Regimen for Alleviation of Refractory Osteoarthritis Pain in Dogs. J Vet Intern Med. 2008;22(1):53–59. (Discussed with dosing detail in the Today's Veterinary Practice review below.)
• Today's Veterinary Practice — Gabapentin and Amantadine for Chronic Pain in Dogs and Cats (dosing, duration, central sensitization, when to choose amantadine vs gabapentin): https://todaysveterinarypractice.com/pain_management/gabapentin-and-amantadine-for-chronic-pain/
• WSAVA 2016 Congress (VIN) — Adjuvant Analgesics II: Gabapentin & Amantadine (mechanism, pharmacokinetics, not for monotherapy): https://www.vin.com/apputil/content/defaultadv1.aspx?pId=19840&catId=105889&id=8249782
• Davies Veterinary Specialists — Amantadine for pain relief (central sensitization, dosing, patient selection): https://www.vetspecialists.co.uk/fact-sheets-post/amantadine
• Veterinary Prescribing Information summary (VetScripts) — Amantadine (mechanism, dog/cat dosing, adverse effects, 21-day minimum): https://new.vetscripts.co.za/wp-content/uploads/formidable/10/Amantidine-new-8.pdf
• Amantadine as a therapeutic option for neuropathic pain in dogs with degenerative lumbosacral stenosis (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC12265245/